• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

帕博西尼治疗晚期乳腺癌4年期间发生进行性多灶性白质脑病，患者有滤泡性淋巴瘤病史。

Progressive multifocal leukoencephalopathy during 4 years of Palbociclib for advanced breast cancer with a history of follicular lymphoma patient.

作者信息

Koyamada Ryosuke, Nishihara Mariko, Masaki Tetsuhiro, Shimada Tomohito, Ishikawa Kazuhiro, Hashimoto Jun, Mori Nobuyoshi, Namai Asami, Yokoo Hideaki, Takahashi Kenta, Suzuki Tadaki, Nakamichi Kazuo, Mori Shinichiro

机构信息

Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.

Department of Hematology, Yokosuka Kyosai Hospital, Yokosuka, Japan.

出版信息

J Neurovirol. 2025 Apr;31(2):191-195. doi: 10.1007/s13365-025-01255-w. Epub 2025 Apr 21.

DOI:10.1007/s13365-025-01255-w
PMID:40259166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12137487/
Abstract

A 67-year-old woman with a history of follicular lymphoma and recurrent breast cancer with multiple metastasis developed PML during receiving fluvestrant plus palbociclib. Rituximab and bendamustine had finished 6.5 years ago. Discontinuing palbociclib and using mirtazapine, she is alive a year after diagnosis of PML. It is rare for PML to be diagnosed long after the last dose of rituximab and bendamustine. We will discuss the possible involvement of palbociclib in the course of PML.

摘要

一名67岁女性，有滤泡性淋巴瘤病史，复发性乳腺癌伴多处转移，在接受氟维司群加帕博西尼治疗期间发生进行性多灶性白质脑病（PML）。利妥昔单抗和苯达莫司汀已于6.5年前停用。停用帕博西尼并使用米氮平后，她在被诊断为PML一年后仍然存活。在最后一剂利妥昔单抗和苯达莫司汀后很长时间才诊断出PML的情况很罕见。我们将讨论帕博西尼在PML病程中可能的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/ed5d5e3a7129/13365_2025_1255_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/7492ffde28b5/13365_2025_1255_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/c0625bb464dd/13365_2025_1255_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/ed5d5e3a7129/13365_2025_1255_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/7492ffde28b5/13365_2025_1255_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/c0625bb464dd/13365_2025_1255_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8344/12137487/ed5d5e3a7129/13365_2025_1255_Fig3_HTML.jpg

相似文献

1
Progressive multifocal leukoencephalopathy during 4 years of Palbociclib for advanced breast cancer with a history of follicular lymphoma patient.帕博西尼治疗晚期乳腺癌4年期间发生进行性多灶性白质脑病，患者有滤泡性淋巴瘤病史。
J Neurovirol. 2025 Apr;31(2):191-195. doi: 10.1007/s13365-025-01255-w. Epub 2025 Apr 21.
2
Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.利妥昔单抗和苯达莫司汀治疗复发滤泡性淋巴瘤后利妥昔单抗维持治疗期间发生的进行性多灶性白质脑病。
Ann Hematol. 2020 Sep;99(9):2191-2192. doi: 10.1007/s00277-020-04143-x. Epub 2020 Jun 17.
3
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance.使用苯达莫司汀联合利妥昔单抗治疗后再用利妥昔单抗维持治疗的滤泡性淋巴瘤患者发生进行性多灶性白质脑病。
Br J Haematol. 2020 May;189(4):e140-e144. doi: 10.1111/bjh.16563. Epub 2020 Mar 9.
4
Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.利妥昔单抗治疗非霍奇金淋巴瘤的HIV阴性患者后发生进行性多灶性白质脑病。病例报告及文献复习
Neuroradiol J. 2014 Dec;27(6):657-64. doi: 10.15274/NRJ-2014-10087. Epub 2014 Dec 1.
5
Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.苯达莫司汀和利妥昔单抗治疗后进展性多灶性白质脑病。
Int J Hematol. 2012 Aug;96(2):274-8. doi: 10.1007/s12185-012-1118-6. Epub 2012 Jun 9.
6
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).一项由意大利淋巴瘤基金会（FIL）开展的 II 期研究，在老年晚期滤泡淋巴瘤患者中采用利妥昔单抗、苯达莫司汀、米托蒽醌（R-BM）短程诱导，随后进行利妥昔单抗巩固治疗。
Br J Haematol. 2021 Apr;193(2):280-289. doi: 10.1111/bjh.17283. Epub 2021 Jan 21.
7
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.米氮平治疗真性红细胞增多症相关的进行性多灶性白质脑病。
J Infect Dis. 2007 Sep 1;196(5):709-11. doi: 10.1086/520514. Epub 2007 Jul 13.
8
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study.苯达莫司汀暴露对滤泡性淋巴瘤患者接受苯达莫司汀与利妥昔单抗联合治疗后淋巴细胞减少风险的临床影响：一项单机构回顾性研究
Ann Hematol. 2022 Jan;101(1):209-211. doi: 10.1007/s00277-020-04388-6. Epub 2021 Jan 3.
9
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.依鲁替尼治疗慢性淋巴细胞白血病后发生的进行性多灶性白质脑病
Cancer Res Treat. 2017 Apr;49(2):548-552. doi: 10.4143/crt.2016.110. Epub 2016 Jul 12.
10
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.由于严重血液学和感染性毒性，苯达莫司汀、米托蒽醌和利妥昔单抗用于未经治疗的高危滤泡性淋巴瘤患者的II期研究提前终止。
Br J Haematol. 2016 Nov;175(3):531-533. doi: 10.1111/bjh.13863. Epub 2015 Dec 18.

本文引用的文献

1
Pneumonitis and cellular immunodeficiency triggered by the CDK 4/6 inhibitor Abemaciclib.CDK 4/6抑制剂阿贝西利引发的肺炎和细胞免疫缺陷。
Transl Breast Cancer Res. 2022 Jan 31;3:9. doi: 10.21037/tbcr-21-19. eCollection 2022.
2
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance.使用苯达莫司汀联合利妥昔单抗治疗后再用利妥昔单抗维持治疗的滤泡性淋巴瘤患者发生进行性多灶性白质脑病。
Br J Haematol. 2020 May;189(4):e140-e144. doi: 10.1111/bjh.16563. Epub 2020 Mar 9.
3
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.
CDK4/6抑制剂帕博西尼引发的严重细胞免疫缺陷
Clin Breast Cancer. 2020 Apr;20(2):e192-e195. doi: 10.1016/j.clbc.2020.01.009. Epub 2020 Feb 20.
4
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.哌柏西利联合氟维司群治疗晚期乳腺癌的总生存期
N Engl J Med. 2018 Nov 15;379(20):1926-1936. doi: 10.1056/NEJMoa1810527. Epub 2018 Oct 20.
5
Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.进行性多灶性白质脑病与血液系统恶性肿瘤：单癌症中心回顾性研究
Blood Adv. 2017 Oct 18;1(23):2041-2045. doi: 10.1182/bloodadvances.2017008201. eCollection 2017 Oct 24.
6
Classifying PML risk with disease modifying therapies.使用疾病修饰疗法对进行性多灶性白质脑病风险进行分类。
Mult Scler Relat Disord. 2017 Feb;12:59-63. doi: 10.1016/j.msard.2017.01.006. Epub 2017 Jan 6.
7
Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.接受苯达莫司汀联合利妥昔单抗治疗的慢性淋巴细胞白血病和惰性非霍奇金淋巴瘤患者的淋巴细胞恢复受损。
Ann Hematol. 2014 Nov;93(11):1879-87. doi: 10.1007/s00277-014-2135-8. Epub 2014 Jun 21.
8
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.恶性黑色素瘤伊匹单抗治疗期间的后部可逆性脑病综合征
J Clin Oncol. 2012 Feb 20;30(6):e76-8. doi: 10.1200/JCO.2011.38.7886. Epub 2011 Dec 27.
9
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.进行性多灶性白质脑病和其他由 JC 病毒引起的疾病：临床特征和发病机制。
Lancet Neurol. 2010 Apr;9(4):425-37. doi: 10.1016/S1474-4422(10)70040-5.
10
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.利妥昔单抗治疗HIV阴性患者后发生的进行性多灶性白质脑病：来自药物不良事件及报告项目研究的57例报告
Blood. 2009 May 14;113(20):4834-40. doi: 10.1182/blood-2008-10-186999. Epub 2009 Mar 5.